JOHNSON INVESTMENT COUNSEL INC - GLOBUS MED INC ownership

GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 372 filers reported holding GLOBUS MED INC in Q1 2022. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.

Quarter-by-quarter ownership
JOHNSON INVESTMENT COUNSEL INC ownership history of GLOBUS MED INC
ValueSharesWeighting
Q3 2023$409,265
-34.9%
8,243
-21.9%
0.01%
-37.5%
Q2 2023$628,802
-10.4%
10,561
-14.8%
0.01%
-11.1%
Q1 2023$702,109
-79.5%
12,396
-73.2%
0.01%
-80.9%
Q4 2022$3,430,308
+39.9%
46,187
+12.2%
0.05%
+30.6%
Q3 2022$2,452,000
+6.5%
41,167
+0.4%
0.04%
+9.1%
Q2 2022$2,302,000
-24.1%
40,998
-0.3%
0.03%
-13.2%
Q1 2022$3,034,000
+1.5%
41,118
-0.7%
0.04%
+2.7%
Q4 2021$2,989,000
-3.4%
41,394
+2.5%
0.04%
-9.8%
Q3 2021$3,094,000
+0.9%
40,377
+2.1%
0.04%
-2.4%
Q2 2021$3,065,000
+26.3%
39,539
+0.5%
0.04%
+16.7%
Q1 2021$2,426,000
+0.5%
39,338
+6.3%
0.04%
-10.0%
Q4 2020$2,413,000
+33.8%
37,005
+1.6%
0.04%
+21.2%
Q3 2020$1,804,000
+2.7%
36,421
-1.0%
0.03%
-8.3%
Q2 2020$1,756,000
+9.3%
36,807
-2.6%
0.04%0.0%
Q1 2020$1,607,000
-35.8%
37,796
-11.2%
0.04%
-23.4%
Q4 2019$2,505,000
+15.5%
42,547
+0.3%
0.05%
+9.3%
Q3 2019$2,169,000
+21.2%
42,431
+0.3%
0.04%
+16.2%
Q2 2019$1,789,000
+3.9%
42,310
+21.3%
0.04%0.0%
Q1 2019$1,722,000
+18.8%
34,869
+4.0%
0.04%
+5.7%
Q4 2018$1,450,000
-35.5%
33,523
-15.4%
0.04%
-30.0%
Q3 2018$2,247,00039,6030.05%
Other shareholders
GLOBUS MED INC shareholders Q1 2022
NameSharesValueWeighting ↓
Consonance Capital Management LP 589,100$45,137,00024.71%
Sterling Investment Advisors, Ltd. 188,123$14,414,0004.29%
Godshalk Welsh Capital Management, Inc. 73,748$5,651,0003.52%
Pembroke Management, LTD 601,447$46,083,0003.47%
Integral Health Asset Management, LLC 150,000$11,493,0003.30%
XXEC, Inc. 51,925$3,978,0003.03%
PARADIGM CAPITAL MANAGEMENT INC/NY 615,000$47,122,0002.42%
Van Berkom & Associates Inc. 946,997$72,559,0002.20%
RTW INVESTMENTS, LP 1,670,811$128,018,0001.93%
Sivik Global Healthcare LLC 95,000$7,279,0001.74%
View complete list of GLOBUS MED INC shareholders